| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1721d75f5bf603447ec5a26b5c1c0be0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_42dcb8afd289e295b65f450020cbfdb4 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7068
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
| filingDate |
2019-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_befa68371e4b7af92221d281879926e5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25c72570d2f90f75a0833d3529715001
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a0f508a39d5b50245511bd6e4129210d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b158a07a12e218de7de1e29de750aa45
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5cf02f290868fe43f60d3d9ca399f20c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66dd42f6feceb80695f5849f863a3d2c |
| publicationDate |
2021-05-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
BR-112021002630-A2 |
| titleOfInvention |
method to treat pancreatic cancer |
| abstract |
The present invention relates to a method of treating pancreatic cancer in a subject in need thereof which comprises administering to the subject an effective amount of a tubulin polymerization inhibiting compound. more particularly, described herein is a method of treating pancreatic ductal adenocarcinoma in a subject in need thereof which comprises administering to the subject an effective amount of a substituted pyrimidine reverse tubulin polymerization inhibitor compound alone or in combination with others chemotherapeutic agents. |
| priorityDate |
2018-08-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |